Citation tools
"Intrapatient 16α-[18F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer." Journal of Nuclear Medicine
66.2
(2025):
194-200.
Web. 22 April. 2025.